|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.90 INR | -3.17% |
|
-3.79% | +43.41% |
| Market Cap | 18.52B 192M 168M 155M 143M 269M 275M 1.85B 729M 9.07B 722M 706M 31.23B | P/E 2024 |
22.4x | P/E 2025 | 21.8x |
|---|---|---|---|---|---|
| Enterprise Value | 18.52B 192M 168M 155M 143M 269M 275M 1.85B 729M 9.07B 722M 706M 31.22B | EV / Sales 2024 |
1.27x | EV / Sales 2025 | 1.45x |
| Free-Float |
57.31% | Yield 2024 * |
-
| Yield 2025 | 0.42% |
| 1 day | -3.17% | ||
| 1 week | -3.79% | ||
| Current month | -0.37% | ||
| 1 month | +15.42% | ||
| 3 months | +40.57% | ||
| 6 months | +56.19% | ||
| Current year | +43.41% |
| 1 week | 57.66 | 64.58 | |
| 1 month | 49.71 | 64.58 | |
| Current year | 33.05 | 64.58 | |
| 1 year | 33.05 | 64.58 | |
| 3 years | 28.6 | 100.9 | |
| 5 years | 23.6 | 100.9 | |
| 10 years | 7.2 | 100.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sanjay Suri
CEO | Chief Executive Officer | 57 | 2026-06-30 |
Sushil Suri
CEO | Chief Executive Officer | 62 | 1992-01-31 |
| Director of Finance/CFO | 59 | 2002-04-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Sushil Suri
CHM | Chairman | 62 | 1992-01-31 |
| Director/Board Member | 57 | 2019-08-12 | |
Savita
BRD | Director/Board Member | - | 2020-06-21 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.17% | -3.79% | - | - | 335M | ||
| +0.85% | -0.80% | +52.79% | +161.33% | 1,051B | ||
| +1.23% | -1.53% | +54.58% | +59.08% | 609B | ||
| +0.04% | +2.58% | +34.47% | +86.33% | 450B | ||
| +0.78% | -0.71% | +29.28% | +24.10% | 330B | ||
| +1.41% | +0.58% | +35.44% | +40.67% | 284B | ||
| -0.27% | -1.87% | +22.34% | +22.51% | 263B | ||
| -1.76% | +2.37% | -20.43% | -38.00% | 223B | ||
| -1.42% | +0.80% | +24.27% | +57.50% | 198B | ||
| -1.48% | +3.43% | +24.08% | +71.67% | 167B | ||
| Average | -0.38% | +0.54% | +28.54% | +53.91% | 397.23B | |
| Weighted average by Cap. | +0.37% | +0.02% | +37.51% | +79.63% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 17.02B 177M 154M 143M 131M 248M 253M 1.7B 670M 8.34B 664M 649M 28.69B | 18.12B 188M 164M 152M 140M 264M 269M 1.81B 713M 8.87B 706M 691M 30.54B |
| Net income | 962M 9.99M 8.73M 8.05M 7.42M 13.99M 14.3M 96.24M 37.86M 471M 37.5M 36.68M 1.62B | 1.18B 12.26M 10.71M 9.88M 9.11M 17.17M 17.55M 118M 46.46M 578M 46.02M 45.01M 1.99B |
| Net Debt | 121M 1.25M 1.09M 1.01M 930K 1.75M 1.79M 12.06M 4.75M 59.04M 4.7M 4.6M 203M | -928K -9.64K -8.42K -7.77K -7.16K -13.5K -13.8K -92.88K -36.53K -454K -36.19K -35.4K -1.56M |
Employees
1,814
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-17 | ₹58.90 | -3.17% | 7,705,689 |
| 26-07-16 | ₹60.83 | -0.67% | 4,567,550 |
| 26-07-15 | ₹61.24 | -2.11% | 10,976,573 |
| 26-07-14 | ₹62.56 | +0.43% | 10,096,836 |
| 26-07-13 | ₹62.29 | +1.75% | 15,187,668 |
- Stock Market
- Stocks
- 500288 Stock
- MOREPENLAB Stock
Select your edition
All financial news and data tailored to specific country editions
















